» Articles » PMID: 33312063

Effect of Propolis and N-acetylcysteine Supplementation on Lipoprotein Subclasses Distribution and Paraoxonase 1 Activity in Subjects with Acute Respiratory Infection

Abstract

Background: Propolis and N-acetylcysteine have positive impact on respiratory tract health. Also, it has been suggested that they have beneficial effects on serum lipid and oxidative stress status, but the available data are limited and mostly gained from animal models. In this study we evaluated the effects of propolis and N-acetylcysteine supplementation (PropoMucil®) on lipid status, lipoprotein subclasses distribution and paraoxonase 1 activity in subjects with acute respiratory infection.

Methods: Twenty subjects with acute respiratory infection were included. PropoMucil® granules for oral solution (80 mg of dry propolis extract and 200 mg of N-acetylcysteine) were administered tree times per day for ten days. Serum lipid profile, paraoxonase 1 activity and low-density and high-density lipoprotein size and subclasses distribution were assessed at baseline and after supplementation.

Results: Following ten days of supplementation lipid status remained unchanged, but a significant increase of low-density lipoprotein particle size and proportion of high-density lipoprotein 3a particles were found (P<0.05). Moreover, supplementation with PropoMucil® significantly improved high-density lipoprotein particles distribution, particularly in those who smoke. There was a moderate increase of paraoxonase 1 activity, but without statistical significance.

Conclusions: The presented study demonstrated that short-term supplementation with PropoMucil® has beneficial effects on low-density and high-density lipoprotein subclasses distribution and paraoxonase 1 activity in subjects with acute respiratory infection particularly in those who smoke.

Citing Articles

In Vitro Antibiofilm Effect of N-Acetyl-L-cysteine/Dry Propolis Extract Combination on Bacterial Pathogens Isolated from Upper Respiratory Tract Infections.

Bozic D, Cirkovic I, Milovanovic J, Bufan B, Folic M, Savic Vujovic K Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004469 PMC: 10674846. DOI: 10.3390/ph16111604.


Allergic Inflammation: Effect of Propolis and Its Flavonoids.

Orsolic N Molecules. 2022; 27(19).

PMID: 36235230 PMC: 9570745. DOI: 10.3390/molecules27196694.


Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review.

Zulhendri F, Chandrasekaran K, Kowacz M, Ravalia M, Kripal K, Fearnley J Foods. 2021; 10(6).

PMID: 34208334 PMC: 8231288. DOI: 10.3390/foods10061360.

References
1.
Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Bogavac-Stanojevic N, Gulan B . LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis. 2009; 210(2):548-54. DOI: 10.1016/j.atherosclerosis.2009.11.040. View

2.
Caliceti C, Rizzo P, Giuliano M . Role of Natural Compounds in Oxidative Stress and Inflammation Linked to Cardiometabolic Disorders: From Biochemical Aspects to Clinical Evidences. Oxid Med Cell Longev. 2018; 2018:1479309. PMC: 5964537. DOI: 10.1155/2018/1479309. View

3.
Patti A, Toth P, Giglio R, Banach M, Noto M, Nikolic D . Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia. Curr Pharm Des. 2017; 23(17):2496-2503. DOI: 10.2174/1381612823666170317145851. View

4.
Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V . Obesity and dyslipidemia. Metabolism. 2018; 92:71-81. DOI: 10.1016/j.metabol.2018.11.005. View

5.
Telo S, Kuluozturk M, Deveci F, Kirkil G, Oner O, Kaman D . Serum Cystatin C Levels in COPD: Potential Diagnostic Value and Relation between Respiratory Functions. J Med Biochem. 2018; 37(4):434-440. PMC: 6298476. DOI: 10.1515/jomb-2017-0064. View